Icade Santé, which is currently 58.3% owned by Icade, announced on 10 September that its registration document had been approved in France by the French financial markets authority (Autorité des marchés financiers, “AMF”). The approval of this document is the first step in its planned IPO on the Euronext Paris market.
Icade Santé's IPO is part of the Icade Group's 2019-2022 strategic plan announced on 7 June 2021. Icade will remain the controlling shareholder in Icade Santé post IPO and will support Icade Santé's growth ambition.
The objective is to make Icade Santé the leading European healthcare real estate platform.the leading European platform. With the IPO, Icade Santé will finance its investment plan of €3bn by the end of 2025 and will accelerate its pan European expansion.
Read the Icade press release
Both Icade Santé’s press release and registration document are available on www.icade-sante.eu/eng
Si vous souhaitez continuer et lire nos vidéos, vous devez nous donner votre accord en cliquant sur le bouton ci-dessous.